| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
1
3
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
B
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 1.36 | 18.72 | -17.35 |
| Stocks | 0.49 | 0.0 | 0.49 |
| Bonds | 62.61 | 0.0 | 62.61 |
| Other | 1.04 | 0.19 | 0.85 |
| Foreign Bonds | 47.25 | 4.75 | 42.5 |
| Foreign Stocks | 0.0 | 0.0 | 0.0 |
| Convertible | 1.41 | 0.0 | 1.41 |
| Preferred | 9.5 | 0.0 | 9.5 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| % Net Assets | |
|---|---|
| Us Long Bond (Cbt) Jun13 | 15.72 |
| Us Ultra Bond (Cbt) Jun13 | 7.58 |
| Us 5yr Note (Cbt) Jun13 | 4.58 |
| Erac Usa Fin Company 144A 5.625% | 1.68 |
| Celgene 5.7% | 1.29 |
| St Jude Med 4.75% | 1.21 |
| Pernod Ricard S A 144A 5.5% | 1.18 |
| Zoetis 144A 4.7% | 1.13 |
| Apple 3.85% | 1.08 |
| Qvc 144A 4.375% | 1.08 |
Bond Ratings (%)
Updated 04.30.2013
| Sector | DEECX |
|---|---|
| AAA | 7.76 |
| AA | 6.47 |
| A | 15.29 |
| BBB | 50.0 |
| BB | 10.15 |
| B | 6.86 |
| Below B | 2.24 |
| Other | 1.23 |
